AHSAN KHAN: Open Payments
NPI 1346245479 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,615 in 28 payments from 8 companies in 2025. Trend: 2023 $54 · 2024 $253 · 2025 $2,615
Travel & lodging: $1,868Food & beverage: $747
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 16 | $2,353 |
| Teva Pharmaceuticals USA, Inc. | 4 | $88 |
| Boston Scientific Corporation | 3 | $79 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| ABBVIE INC. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: AMS 700, UZEDY, AUSTEDO XR, Auvelity, VRAYLAR, REXULTI, INVEGA SUSTENNA, CAPLYTA.
Industry payments across OK — which companies pay providers there.
